跳至內容

尼莫拉唑

維基百科,自由的百科全書
尼莫拉唑
臨床資料
AHFS/Drugs.com國際藥品名稱
ATC碼
識別資訊
  • 4-[2-(5-nitro-1H-imidazol-1-yl)ethyl]morpholine
CAS號6506-37-2
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard英語CompTox Chemicals Dashboard (EPA)
ECHA InfoCard100.026.723 編輯維基數據鏈接
化學資訊
化學式C9H14N4O3
摩爾質量226.24 g·mol−1
3D模型(JSmol英語JSmol
  • C1COCCN1CCN2C=NC=C2[N+](=O)[O-]
  • InChI=1S/C9H14N4O3/c14-13(15)9-7-10-8-12(9)2-1-11-3-5-16-6-4-11/h7-8H,1-6H2
  • Key:MDJFHRLTPRPZLY-UHFFFAOYSA-N

尼莫拉唑INNnimorazole,開發代號:K-1900),分子式C9H14N4O3,是一種5-硝基咪唑抗寄生蟲藥[1],也用作頭頸癌藥物[2][3]

參考文獻

  1. ^ Roy RB, Laird SM, Heasman L. Treatment of trichomoniasis in the female. A comparison of metronidazole and nimorazole. The British Journal of Venereal Diseases. August 1975, 51 (4): 281–4. PMC 1046566可免費查閱. PMID 1098732. doi:10.1136/sti.51.4.281. 
  2. ^ Henk JM, Bishop K, Shepherd SF. Treatment of head and neck cancer with CHART and nimorazole: phase II study. Radiotherapy and Oncology. January 2003, 66 (1): 65–70. PMID 12559522. doi:10.1016/S0167-8140(02)00284-0可免費查閱. 
  3. ^ Clinical trial number NCT01507467 for "IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck" at ClinicalTrials.gov

外部連結